• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体切割联合内界膜剥除术治疗缺血性中央视网膜静脉阻塞抗血管内皮生长因子治疗后持续性黄斑水肿

Pars Plana Vitrectomy Combined with Internal Limiting Membrane Peeling to Treat Persistent Macular Edema after Anti-Vascular Endothelial Growth Factor Treatment in Cases of Ischemic Central Retinal Vein Occlusion.

作者信息

Shirakata Yukari, Fujita Tomoyoshi, Nakano Yuki, Shiraga Fumio, Tsujikawa Akitaka

机构信息

Department of Ophthalmology, Kagawa University Faculty of Medicine, Takamatsu, Okayama, Japan.

Department of Ophthalmology, Okayama University, Okayama, Japan.

出版信息

Case Rep Ophthalmol. 2016 Jan 8;7(1):1-8. doi: 10.1159/000443322. eCollection 2016 Jan-Apr.

DOI:10.1159/000443322
PMID:26889152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4748766/
Abstract

OBJECTIVE

To evaluate the efficacy of pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling in cases of ischemic central retinal vein occlusion (CRVO) where macular edema (ME) persisted after anti-vascular endothelial growth factor (anti-VEGF) treatment.

METHODS

Fifteen eyes with ischemic CRVO-related ME were included in the study. Nine were treated with panretinal photocoagulation after initial examination. Anti-VEGF agents were injected intravitreally. Persistent ME was treated with PPV combined with ILM peeling. During surgery, laser photocoagulation was further applied to the non-perfused area.

RESULTS

Mean retinal thickness gradually decreased after surgery (p = 0.024 at 6 months), although visual acuity did not improve significantly during the follow-up period (14.7 ± 11.6 months). Neovascular glaucoma subsequently developed in three cases and a trabeculectomy was performed in one case.

CONCLUSION

In eyes with ischemic CRVO, PPV combined with ILM peeling contributed to a reduction in persistent ME. However, there was no significant improvement in visual acuity.

摘要

目的

评估在抗血管内皮生长因子(抗VEGF)治疗后黄斑水肿(ME)仍持续存在的缺血性中央视网膜静脉阻塞(CRVO)病例中,玻璃体切割术(PPV)联合内界膜(ILM)剥除术的疗效。

方法

本研究纳入15只患有缺血性CRVO相关ME的眼睛。9只眼睛在初次检查后接受了全视网膜光凝治疗。玻璃体内注射抗VEGF药物。持续性ME采用PPV联合ILM剥除术治疗。手术过程中,对无灌注区进一步进行激光光凝。

结果

术后平均视网膜厚度逐渐降低(6个月时p = 0.024),尽管在随访期间视力没有显著改善(14.7 ± 11.6个月)。随后3例发生新生血管性青光眼,1例行小梁切除术。

结论

在患有缺血性CRVO的眼睛中,PPV联合ILM剥除术有助于减轻持续性ME。然而,视力没有显著改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/015f/4748766/b8a263d93598/cop-0007-0001-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/015f/4748766/b8a263d93598/cop-0007-0001-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/015f/4748766/b8a263d93598/cop-0007-0001-g01.jpg

相似文献

1
Pars Plana Vitrectomy Combined with Internal Limiting Membrane Peeling to Treat Persistent Macular Edema after Anti-Vascular Endothelial Growth Factor Treatment in Cases of Ischemic Central Retinal Vein Occlusion.玻璃体切割联合内界膜剥除术治疗缺血性中央视网膜静脉阻塞抗血管内皮生长因子治疗后持续性黄斑水肿
Case Rep Ophthalmol. 2016 Jan 8;7(1):1-8. doi: 10.1159/000443322. eCollection 2016 Jan-Apr.
2
Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane.玻璃体切割联合吲哚菁绿辅助内界膜剥除术后黄斑水肿患者的视力预后
Graefes Arch Clin Exp Ophthalmol. 2004 Apr;242(4):273-8. doi: 10.1007/s00417-003-0731-8. Epub 2004 Mar 23.
3
Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion.玻璃体后皮质剥除的玻璃体切除术治疗视网膜静脉阻塞继发的黄斑水肿
Eur J Ophthalmol. 2009 Nov-Dec;19(6):1055-62. doi: 10.1177/112067210901900625.
4
Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments.玻璃体切除术联合内界膜剥除术治疗抗血管内皮生长因子治疗后视网膜分支静脉阻塞所致复发性黄斑水肿。
Clin Ophthalmol. 2016 Feb 5;10:277-83. doi: 10.2147/OPTH.S85751. eCollection 2016.
5
Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion.玻璃体内切割术和内界膜剥除术治疗视网膜中央静脉阻塞和半侧视网膜静脉阻塞继发黄斑水肿的长期疗效。
Retina. 2010 Jan;30(1):117-24. doi: 10.1097/IAE.0b013e3181bced68.
6
Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases.视网膜静脉阻塞性黄斑水肿减压的内界膜剥除术:14例报告
Retina. 2004 Jun;24(3):348-55. doi: 10.1097/00006982-200406000-00002.
7
Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion.玻璃体切割术、内界膜剥除术及全视网膜光凝术治疗视网膜中央静脉阻塞继发的黄斑水肿
Am J Ophthalmol. 2009 Apr;147(4):627-633.e1. doi: 10.1016/j.ajo.2008.10.024. Epub 2009 Feb 4.
8
Surgical macular decompression for macular edema in retinal vein occlusion.视网膜静脉阻塞性黄斑水肿的手术性黄斑减压术
Can J Ophthalmol. 2007 Feb;42(1):116-22.
9
Efficacy of internal limiting membrane peeling for diabetic macular edema after preoperative anti-vascular endothelial growth factor injection.术前抗血管内皮生长因子注射后内界膜剥除术治疗糖尿病性黄斑水肿的疗效
Int J Ophthalmol. 2020 Nov 18;13(11):1758-1764. doi: 10.18240/ijo.2020.11.12. eCollection 2020.
10
Pars plana vitrectomy and internal limiting membrane peeling for macular oedema secondary to retinal vein occlusion: a pilot study.玻璃体切割术联合内界膜剥除术治疗视网膜静脉阻塞继发黄斑水肿的初步研究
Ann Acad Med Singap. 2007 Apr;36(4):293-7.

引用本文的文献

1
Vitrectomy for macular edema due to retinal vein occlusion.视网膜静脉阻塞所致黄斑水肿的玻璃体切除术
Clin Ophthalmol. 2019 Jun 13;13:969-984. doi: 10.2147/OPTH.S203212. eCollection 2019.

本文引用的文献

1
Strategy for the management of macular edema in retinal vein occlusion: the European VitreoRetinal Society macular edema study.视网膜静脉阻塞性黄斑水肿的管理策略:欧洲玻璃体视网膜学会黄斑水肿研究
Biomed Res Int. 2015;2015:870987. doi: 10.1155/2015/870987. Epub 2015 Jan 29.
2
Strategy for the management of diabetic macular edema: the European vitreo-retinal society macular edema study.糖尿病性黄斑水肿的管理策略:欧洲玻璃体视网膜学会黄斑水肿研究
Biomed Res Int. 2015;2015:352487. doi: 10.1155/2015/352487. Epub 2015 Jan 28.
3
Ocular vascular occlusive disorders: natural history of visual outcome.
眼部血管阻塞性疾病:视力预后的自然史。
Prog Retin Eye Res. 2014 Jul;41:1-25. doi: 10.1016/j.preteyeres.2014.04.001. Epub 2014 Apr 21.
4
A meta-analysis of anti-vascular endothelial growth factor remedy for macular edema secondary to central retinal vein occlusion.抗血管内皮生长因子治疗视网膜中央静脉阻塞继发黄斑水肿的荟萃分析。
PLoS One. 2013 Dec 23;8(12):e82454. doi: 10.1371/journal.pone.0082454. eCollection 2013.
5
Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study.雷珠单抗治疗视网膜静脉阻塞患者的长期疗效:RETAIN 研究。
Ophthalmology. 2014 Jan;121(1):209-219. doi: 10.1016/j.ophtha.2013.08.038. Epub 2013 Oct 7.
6
Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO Study.玻璃体内注射阿柏西普治疗视网膜中央静脉阻塞引起的黄斑水肿:3 期 GALILEO 研究的一年结果。
Ophthalmology. 2014 Jan;121(1):202-208. doi: 10.1016/j.ophtha.2013.08.012. Epub 2013 Sep 29.
7
Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab.玻璃体切割术对玻璃体内注射贝伐单抗后视网膜分支静脉阻塞所致复发性黄斑水肿的影响。
J Ophthalmol. 2013;2013:415974. doi: 10.1155/2013/415974. Epub 2013 Feb 20.
8
Testing the effectiveness of intravitreal ranibizumab during 12 months of follow-up in venous occlusion treatment.在静脉阻塞治疗的12个月随访期间测试玻璃体内注射雷珠单抗的有效性。
Clin Ter. 2012 Nov;163(6):e413-22.
9
Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.雷珠单抗治疗视网膜静脉阻塞所致黄斑水肿的长期随访:HORIZON 试验。
Ophthalmology. 2012 Apr;119(4):802-9. doi: 10.1016/j.ophtha.2011.12.005. Epub 2012 Feb 1.
10
Pars plana vitrectomy and internal limiting membrane peeling for macular edema secondary to retinal vein occlusion.玻璃体切割术联合内界膜剥除术治疗视网膜静脉阻塞继发黄斑水肿
Clin Ophthalmol. 2011;5:1089-93. doi: 10.2147/OPTH.S23164. Epub 2011 Aug 5.